Clinical trial
Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
NCT01009944 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Mechanisms in Human Hypertension RAAS Inhibition Study
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 31, 2007
- Completion date
- March 19, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.